Michael Meuse MD

[Makenzie Dunaway @MakenzieDunaway]

Congratulations to @MeuseVIR and @AtriumHealth Cabarrus for being the first in Charlotte and surrounding areas to implant Abbott’s Esprit™ BTK Everolimus Eluting Resorbable Scaffold System. This milestone offers a life changing therapy that will help treat the millions with CLTI

[Shockwave Medical @ShockwaveIVL]

An outstanding display of #ShockwaveIVL #BTK capabilities – well done Dr. @MeuseVIR at @AtriumHealth in Charlotte, NC. Patient with toe & hindfoot tissue loss, used #ShockwaveS4 3.0x40 in PT and 2.5x40 in distal peroneal. Great outcome!

ISI https://t.co/Q2peu4kDd6 #TwittIR #IRad

[Michael Meuse MD @MeuseVIR]

@saherssabri @NikkiKeefe @kstadt911 @SIRspecialists @UVARadiology @AlanMatsumotoMD @UVA_IR @ZHaskal @LukeWilkins_UVA @UVA @VIRkhaja @tarheeldylan Oldskool gift from Dake. Amazing year.

[Michael Meuse MD @MeuseVIR]

@LessneVIR @CLTRadiology @SIRspecialists @VascularSVS Gotta straighten out those j gaps

[Cat Jennings @bsc_vascular]

LIVE @ #TCT2018: IMPERIAL H2H Trial Results: Statistically significant difference in primary patency with Eluvia DES 88.5% vs ZilverPTX 79.5% at 12 months #EluviaDES #IMPERIAL

[Mark Lessne, MD @LessneVIR]

Great Q&A & insight on #IRad's essential role in acute #Stroke therapy... And I'm pretty sure i took one of those photos 📸 @CLTRadiology @VV_VIRNIR @JohnsHopkinsIR

https://t.co/X0XTmSVUI7

[Michael Meuse MD @MeuseVIR]

@MeuseVIR strut irritating a jejunal branch with pain. Pain resolved following #filterout

[Michael Meuse MD @MeuseVIR]

Its friday so you know what that means #filterout

[Michael Meuse MD @MeuseVIR]

Im old, but still down with dominating tibials @kmadass @drsavealimb @Vascularman @LessneVIR

[Michael Meuse MD @MeuseVIR]

The face of CLI - another happy patient leaves my office this afternoon on both of her feet #CLIFighters

[Robert A Lookstein MD, MHCDL @roblookstein]

Alert!! New @CLI_Global publication #CLIFighters Determinants of Long‐Term Outcomes and Costs in the Management of Critical Limb Ischemia: A Population‐Based Cohort Study | Journal of the American Heart Association https://t.co/eKigTuVmkP @Mustapja @docmrjaff @DrBTKatzen

[Michael Meuse MD @MeuseVIR]

Hey fellow IR colleagues. We are hiring! Come work with us. https://t.co/GzporxsZjA

[Michael Meuse MD @MeuseVIR]

@kmadass @gallipeau_chris i feel like the hawkone S is more occlusive in tibs and im only making opposing cuts, im more agressive above knee

[Michael Meuse MD @MeuseVIR]

@kmadass @gallipeau_chris kumar i almost always use epd with hawk for fempop, but rarely in tibials.

[Michael Meuse MD @MeuseVIR]

@DrArteryOpener @YouTube I want in on the Modern Vascular franchise

[Michael Meuse MD @MeuseVIR]

@DrArteryOpener @YouTube Scott - fantastic. Neuropathy is a novel marketing angle for PVD screening capture. Let us know how this goes.

[Sabeen Dhand @SDhandMD]

Remotely occluded SFA stents s/p fempop vein bypass 3 yrs ago (s/p lysis x2), now w severe rest pain. Rec BKA, unless hail mary can be done. Challenge accepted!
Complex intervention: controlled rupture with brand new CFA-POP bypass.
#CLIFighters

@kmadass @AlexCVIR @LessneVIR

[Fadi Saab @FadiSaab17]

Welcome @kkansagra7 to @CLI_Global. Let’s bring in more fellows into the conversation #CLIFighters @DrArteryOpener @SDhandMD @drsavealimb @Mustapja @keithppereira @SriniTummala @TimYatesMD @MeuseVIR https://t.co/eoXoYMQm6b

[Mark Lessne, MD @LessneVIR]

One the greats, @DrBTKatzen, advocating for patients for so long. Now preaching importance of being #CLIfighters to save limbs, save lives. I'm beyond honored to be part of this movement! #stopthechop #IRad @CLTRadiology @Carolinas https://t.co/FzzWrGsbQs

[Robert A Lookstein MD, MHCDL @roblookstein]

Do you want to be one of the #CLIFighters? Then you MUST join @CLI_Global #thetimeisnow #stopthechop @SIRspecialists @SIRRFS @bsc_pi @MountSinaiIR